The newly FDA-cleared MicrO2 sleep apnea device is compact yet strong, and easy to use

The FDA has cleared MicroDental Laboratories’ MicrO₂Obstructive Sleep Apnea device, which features a patent-pending design and precision milling production process.

Also the MicrO₂utilizes a PMMA material that is cured under controlled conditions, which reportedly allows the device to be compact yet strong, precise and predictable.

“Dentists are the front line for screening and managing patients with Obstructive Sleep Apnea,” said Kim Bradshaw, CEO and President of MicroDental Laboratories. “Many of our partner dentists asked for a small, precise, and easy to use Obstructive Sleep Apnea device. The MicrO₂ device has been designed, from the very beginning, with these goals in mind.”

While you were sleeping: Sleep apnea and oral appliance therapy

Another feature of the MicrO₂is its approach to tritration that is said to be intended to make the device easier for both the dentist and the patient to use.

“The MicrO₂ does not require patients to manage any mechanical adjustments, such as turning screws, or changing positions with elastics. Instead the MicrO₂ comes with one pair of Upper and Lower arches set to the prescription, and a second pair set in any amount of advancement increments. Advancements are easily achieved by simply removing the current Upper or Lower arch device and inserting the next advancement device in the MicrO₂ series,” commented Laura Sheppard, Sr. Director of Compliance and Regulatory Affairs for MicroDental. 

Snoring increases risk of cancer

Affecting over 18 million Americans, OSA is linked to snoring, memory loss, headaches, depression, as well as an increased risk of stroke, heart problems and motor vehicle accidents.

For more information about the MicrO₂device, or to get additional details on sending cases, call 1-800-229-0936 or head to www.microdental.com.